Blueprint Medicines (Netherlands) B.V.
2 products tracked · names used in filings: Blueprint Medicines (Netherlands) B.V.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Gavreto pralsetinib | Withdrawn | 2021-11-18 |
| 🇪🇺 | Ayvakyt avapritinib | Authorised | 2020-09-24 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.